Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOLF IDA/Oncho: Safety and Efficacy of IDA for Onchocerciasis
NCT04188301Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2019
- Primary completion
- Mar 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diethylcarbamazine in onchocerciasis, sponsored by Washington University School of Medicine. Started Dec 2019; status: completed.
02
Drugs
diethylcarbamazine
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT04188301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04188301.